In contrast, another study showed that intraperitoneally administered AGE-rat serum albumin (CML) resulted in increased levels of α-SMA without having an influence on fibrosis. This evidence concerns the gene ACTA1 and chronic myelogenous leukemia, BCR-ABL1 positive.